Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Alpha Wealth Funds - The Insiders Fund Portfolio Manager | “The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. Biotech drug discovery and innovation will have to be one of the main beneficiaries to justify the massive capital investment in AI. Broad exposure to this theme is a good way to diversify and reduce risk in lieu of specific equity ideas. For instance, Isomorphic Labs—a Google DeepMind spin-off led by Nobel laureate Demis Hassabis—commercializes AI-driven drug discovery using AlphaFold technology. Backed by Alphabet and Thrive Capital, it recently secured $2.1 billion in funding. Through partnerships with Eli Lilly and Novartis, the firm is advancing AI-designed medicines toward clinical trials.” | NEUTRAL | Q2 2026 Jul 17, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
